Pirfenidone Tablet
Product Images NDC 51407-913

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Pirfenidone (NDC 51407-913). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-913-27ol (Pirfenidone 267 mg)

This text contains information about a medication with NDC 51407-913-27. The tablet contains 267 mg of a substance called Pirfenidone. The pharmacist is advised to dispense patient information with each prescription. The medication should be stored between 20° - 25°C (68° - 77°F), with excursions permitted from 15° - 30°C (59° - 86°F). For more patient information, the text provides a link to visit at https://gsms.us/. The medication should be kept out of the reach of children.*

FDA Label Image

51407-914-90ol (Pirfenidone 801 mg)

FDA Label Image

Figure1.jpg (Figure1)

This description provides data on the percentage of patients showing worsening or no decline in Forced Vital Capacity (%FVC) when treated with Pirfenidone compared to a Placebo. The data shows an absolute change in %FVC from baseline to week 52, with 30% and 10% representing the decrease and increase respectively. The study involved 278 participants in the Pirfenidone group and 277 participants in the Placebo group.*

FDA Label Image

Figure2.jpg (Figure2)

This text provides information on the mean change in Forced Vital Capacity (FVC) in milliliters (mL) comparing the effects of Pirfenidone with a sample size of 278 to a placebo with a sample size of 277 over various weeks. The data shows a decrease in FVC levels over time in both groups.*

FDA Label Image

Figure3.jpg (Figure3)

This text provides statistics on the percentage of patients alive over time when comparing the drug Pirfenidone with a placebo. The data includes the number of patients in each group, hazard ratio (HR) and its 95% Confidence Interval (Cl). The chart shows the percentage of patients alive at different time points and includes the number of patients at risk in each group.*

FDA Label Image

Structure.jpg (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.